Anti-CBFb antibody [EPR6322] - BSA and Azide free
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal CBFb antibody. Carrier free. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Mouse, Rat, Human samples.
View Alternative Names
Core-binding factor subunit beta, CBF-beta, Polyomavirus enhancer-binding protein 2 beta subunit, SL3-3 enhancer factor 1 subunit beta, SL3/AKV core-binding factor beta subunit, PEA2-beta, PEBP2-beta, CBFB
- WB
Unknown
Western blot - Anti-CBFb antibody [EPR6322] - BSA and Azide free (AB248572)
Blocking/Diluting buffer : 5% NFDM/TBST
Loading Control : Rabbit monoclonal [EPR16891] to GAPDH (ab181602)
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab133600).
All lanes:
Western blot - Anti-CBFb antibody [EPR6322] (<a href='/en-us/products/primary-antibodies/cbfb-antibody-epr6322-ab133600'>ab133600</a>) at 1/1000 dilution
Lane 1:
Raji (Human Burkitt's lymphoma B lymphocyte) whole cell lysate at 20 µg
Lane 2:
HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 3:
K-562 (Human chronic myelogenous leukemia lymphoblast) whole cell lysate at 20 µg
Lane 4:
Jurkat (Human T cell leukemia T lymphocyte) whole cell lysate at 20 µg
Lane 5:
RAW 264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysate at 20 µg
Lane 6:
Mouse spleen lysate at 20 µg
Lane 7:
Mouse thymus lysate at 20 µg
Lane 8:
Rat spleen lysate at 20 µg
Lane 9:
Rat thymus lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 22 kDa
Observed band size: 22 kDa
false
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-CBFb antibody [EPR6322] - BSA and Azide free (AB248572)
Immunocytochemistry/Immunofluorescence analysis of Jurkat (Human T cell leukemia T lymphocyte) cells labeling CBFb with purified ab133600 at 1/100 dilution (10 μg/mL). Cells were fixed in 100% Methanol and permeabilized with None. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1/200 (2.5 μg/mL). Goat anti rabbit IgG (Alexa Fluor® 488,ab150077) was used as the secondary antibody at 1/1000 (2 μg/mL) dilution. DAPI (blue) was used as nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab133600).
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-CBFb antibody [EPR6322] - BSA and Azide free (AB248572)
Intracellular Flow Cytometry analysis of K-562 (Human chronic myelogenous leukemia lymphoblast) cells, labeling CBFb with purified ab133600 at 1/100 dilution (10μg/mL) (Red). Cells were fixed with 4% Paraformaldehyde and permeabilised with 90% Methanol. A Goat anti rabbit IgG (Alexa Fluor®488, ab150077) secondary antibody was used at 1/2000. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue). This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab133600).
- WB
Lab
Western blot - Anti-CBFb antibody [EPR6322] - BSA and Azide free (AB248572)
ab133600 was shown to react with CBFb in wild-type A431 cells in western blot. Loss of signal was observed when CBFB knockout sample was used. Membranes were blocked in 2 % BSA in TBS-T (0.1 % Tween®) before incubation with ab133600 overnight at 4°C at a 1 in 1000 dilution and ab184095 (Mouse Anti-GAPDH antibody [mAbcam 9484] - Alexa Fluor® 680) at a 1 in 1000 dilution. Blots were incubated with HRP conjugated Goat anti-Rabbit (H+L) secondary antibody at 1/5000 for 1 hour at room temperature before development with Optiblot ECL reagent (ab133456) and imaging.
All lanes:
Western blot - Anti-CBFb antibody [EPR6322] (<a href='/en-us/products/primary-antibodies/cbfb-antibody-epr6322-ab133600'>ab133600</a>) at 1/1000 dilution
Lane 1:
Wild-type A-431 (Human epidermoid carcinoma cell line) whole cell lysate at 20 µg
Lane 2:
CBFB knockout A-431 (Human epidermoid carcinoma cell line) whole cell lysate at 20 µg
Lane 2:
Western blot - Human CBFB knockout A-431 cell line (<a href='/en-us/products/cell-lines/human-cbfb-knockout-a-431-cell-line-ab270472'>ab270472</a>)
Lane 3:
K562 (Human chronic myelogenous leukemia lymphoblast cell line ) whole cell lysate at 20 µg
Lane 4:
HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Predicted band size: 22 kDa
Observed band size: 24 kDa
false
Exposure time: 150s
- WB
Lab
Western blot - Anti-CBFb antibody [EPR6322] - BSA and Azide free (AB248572)
This data was developed using the same antibody clone in a different buffer formulation (ab133600).
Lanes 1 - 4 : Merged signal (red and green). Green - ab133600 observed at 22 kDa. Red - loading control ab7291 (Mouse anti-Alpha Tubulin [DM1A]) observed at 55kDa.
ab133600 was shown to react with CBFb in wild-type A431 cells in western blot with loss of signal observed in CBFB knockout sample. Wild-type and CBFB knockout A431 cell lysates were subjected to SDS-PAGE. Membranes were blocked in 2% BSA in TBS-T (0.1% Tween®) before incubation with ab133600 and ab7291 (Mouse anti-Alpha Tubulin [DM1A]) overnight at 4°C at a 1 in 1000 Dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-CBFb antibody [EPR6322] (<a href='/en-us/products/primary-antibodies/cbfb-antibody-epr6322-ab133600'>ab133600</a>) at 1/1000 dilution
Lane 1:
Wild-type A-431 (Human epidermoid carcinoma cell line) whole cell lysate at 20 µg
Lane 2:
CBFB knockout A-431 (Human epidermoid carcinoma cell line) whole cell lysate at 20 µg
Lane 2:
Western blot - Human CBFB knockout A-431 cell line (<a href='/en-us/products/cell-lines/human-cbfb-knockout-a-431-cell-line-ab270472'>ab270472</a>)
Lane 3:
K562 (Human chronic myelogenous leukemia lymphoblast cell line ) whole cell lysate at 20 µg
Lane 4:
HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Predicted band size: 22 kDa
Observed band size: 22 kDa
false
Related conjugates and formulations (2)
-
Anti-CBFb antibody [EPR6322]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-CBFb antibody [EPR6322]
Reactivity data
Product details
ab248572 is the carrier-free version of ab133600.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CBFb forms a complex with RUNX transcription factors facilitating their function. The complex is essential for hematopoiesis as it regulates the expression of genes critical for blood cell differentiation and proliferation. CBFb is involved in bone development influencing the formation of bone-related genes. This CBFb/RUNX complex plays a role in regulating the cell cycle and apoptosis fundamental processes for maintaining cellular integrity.
Pathways
More than one signaling pathway includes CBFb's involvement. Particularly it participates in the Wnt signaling pathway an important player in cell differentiation. Additionally CBFb/RUNX complex regulates genes downstream in the TGF-beta signaling pathway impacting cellular proliferation and differentiation. Through these pathways CBFb is linked to proteins like SMAD3 further emphasizing its role in mediating various biological processes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Associated Products
Alternative Version
Primary Antibodies
AB208764
Alexa Fluor® 647 Anti-CBFb antibody [EPR6322]
primary-antibodies
alexa-fluor-647-cbfb-antibody-epr6322-ab208764
0
(0 reviews)
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com